Publications by authors named "Premal D Lulla"

Claim this Profile
N
New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma.
Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Premal D Lulla

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma.
Roni Shouval, Christopher Strouse, Soyoung Kim, Temitope Oloyede, Sairah Ahmed, Premal D Lulla

Transplant Cell Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incipient clonal hematopoiesis is accelerated following CD30.CAR-T therapy.
Chiraag D Kapadia, Gerardo Rosas, Sachin G Thakkar, Mengfen Wu, Virginia Torrano, Premal D Lulla

Cytotherapy· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging Challenges to Cellular Therapy of Cancer.
Premal D Lulla, Malcolm Brenner

Cancer J· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
David H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill, Carlos A Ramos, Nabil Ahmed, Premal D Lulla

Blood· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.
Swati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, Manik Kuvalekar, Ayumi Watanabe, Premal D Lulla

Blood· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR T cells and autologous transplantation can coexist for DLBCL.
Premal D Lulla

Blood· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-specific T's may offset therapeutically endangered B's.
LaQuisa C Hill, Premal D Lulla

Blood· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
Premal D Lulla, Swati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, Ayumi Watanabe, Suhasini Lulla

Blood· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects.
Spyridoula Vasileiou, Premal D Lulla, Ifigeneia Tzannou, Ayumi Watanabe, Manik Kuvalekar

J Clin Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.
Carlos A Ramos, Natalie S Grover, Anne W Beaven, Premal D Lulla, Meng-Fen Wu

J Clin Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive Cell Therapy for Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia.
Premal D Lulla, Maksim Mamonkin, Malcolm K Brenner

Cancer J· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and clinical effects of administering a multiantigen-targeted T cell therapy to patients with multiple myeloma.
Premal D Lulla, Ifigeneia Tzannou, Spyridoula Vasileiou, George Carrum, Carlos A Ramos

Sci Transl Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma.
Premal D Lulla, LaQuisa C Hill, Carlos A Ramos, Helen E Heslop

Clin Adv Hematol Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained complete remission of metastatic hepatocellular carcinoma with single agent sorafenib.
Premal D Lulla, Jonathan E Brammer, Salman Bandeali, Garret R Lynch

J Gastrointest Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis